Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us 
About
AIChE Annual MeetingAIChE Annual Meeting
Not Confirmed
Not Confirmed
02-06 November, 2025
Not Confirmed
Not Confirmed
03-06 November, 2025
Not Confirmed
Not Confirmed
03-05 November, 2025
List your booth number for exhibitions, ask us 
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
AIChE Annual MeetingAIChE Annual Meeting
Industry Trade Show
Not Confirmed
02-06 November, 2025
Industry Trade Show
Not Confirmed
03-06 November, 2025
Industry Trade Show
Not Confirmed
03-05 November, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-expanding-our-cdmo-capabilities-to-meet-the-next-wave-of-complex-therapies-starting-with-oncology
VLOG #PharmaReel
[Sponsored by another company] 
					DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-chemexpress-invest-in-adc-facilities-cohance-to-set-up-oligonucleotide-facility-in-india

20 Sep 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hepagene-therapeutics-announces-fda-clearance-of-investigational-new-drug-application-ind-for-hpg7233-thr-beta-agonist-301933223.html

25 May 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hepagene-therapeutics-to-present-at-the-european-association-for-the-study-of-the-liver-easl-congress-2023-301834650.html

02 Dec 2021
// PRESS RELEASE
https://www.pharmacompass.com/pdf/news/hepagene-therapeutics-initiates-the-rise-study-a-phase-iia-clinical-trial-of-hpg1860-in-patients-with-nash-1641805439.pdf

02 Dec 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/hepagene-therapeutics-initiates-the-rise-study-a-phase-iia-clinical-trial-of-hpg1860-in-patients-with-nash-301434639.html

23 Aug 2021
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/hepagene-therapeutics-inc-announces-positive-results-from-phase-i-trial-of-hpg1860-301359762.html
ABOUT THIS PAGE
